Month: August 2013

August 1, 2013
Bayer recruits children to long-acting trial

Bayer HealthCare has started to enroll children in an international phase III trial to evaluate its investigational compound BAY 94-9027 for the treatment of haemophilia A. This follows the completion of enrollment of adult patients into the PROTECT VIII trial (PROphylaxis in haemophilia A patienTs via directly pEgylated long-aCTing rFVIII). The PROTECT VIII Kids trial …

Read article